Journal of Medical Oncology and Therapeutics

Personalized and precision medicine as a model of healthcare of the newest generation to get armed with innovative translational platforms, new knowledge and tools, upgraded education and mentality to secure the impact of the latter

Annual Congress on Oncology and Biomarkers Summit
November 27-28, 2017 | Atlanta, USA

Sergey Suchkov

I M Sechenov First Moscow State Medical University, Russia

Posters & Accepted Abstracts : J Med Oncl Ther

Abstract:

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized medicine (PM). To achieve the implementation of PM concept, it is necessary to create a fundamentally new strategy based upon the subclinical recognition of biopredictors of hidden abnormalities long before the disease clinically mani-fests itself. Each decision-maker values the impact of their decision to use PM on their own budget and well-being, which may not necessarily be optimal for society. It would be ex-tremely useful to integrate data harvesting from different databanks for applications such as prediction and personalization of further treatment to thus provide more tailored measures for the patients resulting in improved patient outcomes, reduced adverse events and more cost-effective use of health care resources. A lack of medical guidelines has been identified by most responders as the predominant barrier for adoption, indicating a need for the develop-ment of best practices and guidelines to support the implementation of PM. Implementation of PM requires a lot before the current model “physician-patient” could be gradually dis-placed by a new model “medical advisorhealthy person-at-risk”. This is the reason for de-veloping global scientific, clinical, social and educational projects in PM to elicit the content of the new branch.

PDF HTML